Generation Bio Co. (GBIO)
NASDAQ: GBIO · Real-Time Price · USD
1.190
+0.110 (10.19%)
Dec 20, 2024, 4:00 PM EST - Market closed
Generation Bio Co. Market Cap
Generation Bio Co. has a market cap or net worth of $79.48 million as of December 20, 2024. Its market cap has decreased by -32.04% in one year.
Market Cap
79.48M
Enterprise Value
-26.55M
1-Year Change
-32.04%
Ranking
Category
Stock Price
$1.19
Market Cap Chart
Since June 12, 2020, Generation Bio Co.'s market cap has decreased from $1.07B to $79.48M, a decrease of -92.58%. That is a compound annual growth rate of -43.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 79.48M | -27.10% |
| Dec 29, 2023 | 109.03M | -53.31% |
| Dec 30, 2022 | 233.53M | -41.89% |
| Dec 31, 2021 | 401.89M | -68.88% |
| Dec 31, 2020 | 1.29B | 20.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genelux | 74.69M |
| Rani Therapeutics Holdings | 74.66M |
| Unicycive Therapeutics | 73.70M |
| Aerovate Therapeutics | 73.05M |
| Ovid Therapeutics | 72.43M |
| Armata Pharmaceuticals | 71.64M |
| Owlet | 71.52M |
| Vicarious Surgical | 71.08M |